SM 10906
a prostacyclin I1 (PGI1) analog; structure given in first source
Networked: 3
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Ganglion Cysts (Ganglion)
|
2. | Mastocytoma
01/01/1994
- " These results demonstrate that SM-10906, a stable PGI1 derivative, is an agonist for the [3H]iloprost-binding (PGI2) receptor, and that it prevents thrombin-induced Ca2+ mobilization through stimulation of the adenylate cyclase system in mastocytoma cells. " 01/01/1994
- " Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells." 01/01/1994
- " The prostacyclin I1 (PGI1) analogue, SM-10906 and its methyl ester, SM-10902, have been compared with the PGI2 analogue, iloprost, with respect to binding to the PGI2 receptor, stimulation of adenylate cyclase activity and inhibition of thrombin-induced Ca2+ mobilization in mastocytoma P-815 cells. "
|
3. | Hypertrophic Cicatrix (Hypertrophic Scar)
|
4. | Cicatrix (Scar)
|
|
Related Drugs and Biologics